Botfet / Company detail

AMGN

approved

Amgen

biotech

Moat score82out of 100

The numbers

Financial metrics

Quality gate and thesis context

Roic13.2%

Gross Margin70.8%

Revenue Cagr9.0%

Fcf Conversion105.0%

Fcf Yield3.4%

Interest Coverage6.1x

Market Cap B$238.6B

Pe27.1

Quality PassPass

Founder LedNo

Thesis AlignedYes

Moat Quant66

Why it may endure

Moat breakdown

Quant: 66 · Curator: 16

Market Share Stability18

Network Effects6

Pricing Power20

Regulatory Moat16

Switching Costs6

Conviction5/10

Leadership6/10

Vision5/10

← Back to the full screener